Status:
UNKNOWN
Study of Medical Ultrasound for Rhizarthrosis
Lead Sponsor:
Waldfriede Hospital
Conditions:
Rhizarthrosis
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
It was never investigated which preservative non-invasive treatments are superior to treat rhizarthrosis. This randomized study compares the effect of 1. hand therapy vs. 2. therapeutic ultrasound vs....
Eligibility Criteria
Inclusion
- Male and female patients aged 40 to 90 years
- Pain intensity in the region of the thumb base in pain phases ≥ 40 mm on the VAS of 0 to 100 mm (relative to the last 24 hours)
- Complaints for at least 3 months
- X-ray Stadium Eaton I-IV at least once secured
Exclusion
- History of surgery on the affected hand, wrist or forearm
- Planned surgery in the next 8 months
- Anticoagulation (Marcumar, Heparin)
- Haemophilia, V. Willebrandt Jürgens syndrome, thrombocytopathy and other blood anomalies
- acute pain medication (\<7 days)
- Systemic medication with corticoids or immunosuppressants
- Intraarterticular injections or RSO within the last 3 months
- Pregnancy, lactation
- Insulin-dependent type I diabetes mellitus
- Significant cognitive impairment
- clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular system, respiratory tract, vascular system, brain, metabolism, thyroid) that could affect the course of the study
- Malignant disease
- Simultaneous participation in an interventional study or participation in an interventional study in the last two months before study inclusion
- Clinically relevant addiction or substance abuse disorder (defined as alcohol, drug and drug abuse)
- Insufficient mental possibility of cooperation
- Therapy with oral anticoagulants (e.g., Marcumar)
- Suspected lack of compliance
- Medical, psychiatric or other conditions that restrict the patient's following abilities: to interpret the study information, to give informed consent, to adhere to the rules of the protocol, or to complete the study
Key Trial Info
Start Date :
October 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04115085
Start Date
October 7 2019
End Date
March 31 2024
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Waldfriede Hospital
Berlin, Germany, 14163